Skip to content

A study on improvement of skin conditions by the supplementation with lactic acid bacteria

A study to evaluate on improvement of skin conditions by the supplementation with lactic acid bacteria - placebo-controlled, randomized, double blind, parallel-group comparison method - - A placebo-controlled, randomized, double-blind, parallel-group study to evaluate of lactic acid bacteria on the skin functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050034
Enrollment
60
Registered
2024-02-01
Start date
2023-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Take 1 capsule of the test food orally after breakfast for 8 weeks Take 1 capsule of the placebo orally after breakfast for 8 weeks

Sponsors

Kaneka Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Japanese female aged over 30 years and under 50 years at the time of the informed consent 2) Subjects who feel their skin is dry 3) Subjects who have received a sufficient explanation of the purpose and content of the study, fully have understand them, and have expressed their intention to participate in the study voluntarily in writing with their abilities to consent to participate in the study

Exclusion criteria

Exclusion criteria: Subjects who met the following exclusion criteria are excluded from the study: 1) regularly use of medicines or supplements for the skin, or regularly user of probiotics supplements 2) have skin disease symptoms such as atopic dermatitis, or scars/ inflammation at the test sites 3) have severe hay fever / allergic symptoms on face 4) have food allergies 5) have disease such as hepatic, renal, gastrointestinal, cardiac, respiratory, endocrine, or metabolic diseases 6) have a history of cosmetic or medical treatments, hormone replacement therapy within the past 6 months, or intend to undergo such treatments during the study period 7) cannot refrain from undergoing tanning / visiting strong sunlight area during the study period 8) cannot refrain from direct sunlight for sports, etc 9) have digestive diseases / a history of digestive surgery 10) Pregnant, lactating, or intending to become pregnant 11) Drinker (20 g/day or more of pure alcohol for 4 or more days per week), or cannot abstain from alcohol for 2 days prior to each examination. 12) Shift workers, late night workers, or have a plan of travel abroad 13) cannot avoid changing / addition of skin care products 14) cannot avoid shaving the skin for 7 days prior to the date of each examination 15) participated in other studies within 1 month prior to the date of informed consent, or have a plan to participate in other studies during this study. 16) deemed inappropriate by the corresponding investigator with a medical license

Design outcomes

Primary

MeasureTime frame
Skin moisture (stratum corneum water content), Trans epidermal water loss, Skin elasticity

Secondary

MeasureTime frame
Other skin conditions (melanin content, erythema, texture, wrinkles, spots, etc.), Stratum corneum analyses, Questionnaire for skin and mental conditions, Izumo scale score, Physical parameters, Hematology parameters, Blood chemical/biochemical parameters, Urine biochemical parameters

Countries

Japan

Contacts

Public ContactJinko Sawashita

Kaneka Corporation Pharma & Supplemental Nutrition Solutions Vehicle

Jinko.Sawashita@kaneka.co.jp050-3133-6396

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026